ROS -mediated anticancer response of potent copper(II) drug entities derived from S, O and N, N chelating donor scaffold: Single X-ray crystal diffraction and spectroscopic studies

化学 单斜晶系 结晶学 细胞毒性 三斜晶系 单晶 螯合作用 氧化还原 晶体结构 立体化学 体外 无机化学 生物化学 有机化学
作者
Shariq Yousuf,Farukh Arjmand,Sartaj Tabassum
出处
期刊:Journal of Molecular Structure [Elsevier]
卷期号:1262: 132989-132989 被引量:3
标识
DOI:10.1016/j.molstruc.2022.132989
摘要

• The structure of complexes 1 and 2 were thoroughly characterized. • The complexes 1 and 2 were synthesized with an idea of attaining a quick biologically Cu(II)/Cu(I) redox cycle. • The high in vitro cytotoxicity exhibited by five coordinated Cu(II) complex. • Mode of binding of 1 and 2 towards ct-DNA was studied. New Cu(II) anticancer drug entities derived from S, O, and N, N donor chelating scaffolds were synthesized and thoroughly characterized by various spectroscopic and single X-ray diffraction studies. The single X-ray crystal structure of 1 and 2 revealed a monoclinic and triclinic crystal system with space group C 2 / c and P -1, respectively. The biomolecular interaction studies of 1 and 2 with ct-DNA were carried out by employing a battery of biophysical techniques, viz., absorption, emission, circular dichroic, and electrochemical (CV) and corroborative results of these experiments demonstrated avid electrostatic binding via surface groove. The synthesized Cu(II) complexes showed high efficacy as ROS generators involving Cu(II)/Cu(I) redox-active pair as evidenced by cleavage assay in the presence of radical scavengers. The ROS generation in the presence of copper-based complexes is considered one of the most favorable cell death mechanisms for the inhibition of cancers. In vitro anticancer activity of 1 and 2 was, therefore, evaluated against a panel of five human cancer cell lines, namely MCF-7, MDA-MB-231, Hop-62, AW1356, and SiHa, and results of cytotoxicity demonstrated good anticancer response against all tested cancerous strains with GI 50 value <10 µM, except by 1 against MDA-MB-231, Hop-62 and AW1356 cell lines. Interestingly, 2 has displayed considerable cytotoxicity against MCF-7, Hop-62, and SiHa cancer cell lines even better than that of standard drug adriamycin. Furthermore, computational DFT studies validated the high binding efficacy and significant cytotoxicity of complex 2, which could be attributed to high positive charge density over the Cu(II) center. ROS induced DNA damage resulted Cell Death.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YHF2发布了新的文献求助10
刚刚
飞艇完成签到,获得积分10
1秒前
1秒前
浮游应助zzl采纳,获得10
3秒前
ding应助动听的网络采纳,获得10
3秒前
科研通AI6应助清秀台灯采纳,获得30
5秒前
5秒前
我是老大应助科研通管家采纳,获得10
5秒前
JamesPei应助科研通管家采纳,获得10
5秒前
领导范儿应助科研通管家采纳,获得10
5秒前
SciGPT应助科研通管家采纳,获得10
5秒前
完美世界应助科研通管家采纳,获得10
5秒前
浮游应助科研通管家采纳,获得10
5秒前
浮游应助科研通管家采纳,获得10
6秒前
浮游应助科研通管家采纳,获得10
6秒前
科研通AI2S应助科研通管家采纳,获得20
6秒前
Owen应助科研通管家采纳,获得10
6秒前
6秒前
隐形曼青应助科研通管家采纳,获得10
6秒前
浮游应助科研通管家采纳,获得10
6秒前
乐乐应助科研通管家采纳,获得10
6秒前
科研通AI6应助科研通管家采纳,获得30
6秒前
Hello应助科研通管家采纳,获得10
6秒前
打打应助科研通管家采纳,获得10
6秒前
传奇3应助科研通管家采纳,获得30
6秒前
香蕉觅云应助科研通管家采纳,获得10
6秒前
会幸福的发布了新的文献求助10
6秒前
Akim应助科研通管家采纳,获得10
6秒前
科研通AI6应助科研通管家采纳,获得10
6秒前
浮游应助科研通管家采纳,获得10
6秒前
天天快乐应助科研通管家采纳,获得10
7秒前
Akim应助科研通管家采纳,获得10
7秒前
科研通AI6应助科研通管家采纳,获得10
7秒前
浮游应助科研通管家采纳,获得10
7秒前
7秒前
7秒前
领导范儿应助科研通管家采纳,获得10
7秒前
7秒前
梦玲完成签到 ,获得积分10
8秒前
9秒前
高分求助中
Aerospace Standards Index - 2025 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Treatise on Geochemistry (Third edition) 1600
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 1000
List of 1,091 Public Pension Profiles by Region 981
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5457360
求助须知:如何正确求助?哪些是违规求助? 4563864
关于积分的说明 14291813
捐赠科研通 4488514
什么是DOI,文献DOI怎么找? 2458558
邀请新用户注册赠送积分活动 1448595
关于科研通互助平台的介绍 1424229